NUE

NUE Operating Cash Flow (Statement)

$4.42BTTM · USD

Period ending:

NUE FY Cash from OperationsUSD
NUE FY Cash from Operations1989-12-31: $98.00M1990-12-31: $214.30M1991-12-31: $173.40M1992-12-31: $205.40M1993-12-31: $271.80M1994-12-31: $424.90M1995-12-31: $447.20M1996-12-31: $450.60M1997-12-31: $577.30M1998-12-31: $641.90M1999-12-31: $604.80M2000-12-31: $820.75M2001-12-31: $495.12M2002-12-31: $497.22M2003-12-31: $494.62M2004-12-31: $1.02B2005-12-31: $2.14B2006-12-31: $2.25B2007-12-31: $1.94B2008-12-31: $2.50B2009-12-31: $1.17B2010-12-31: $866.79M2011-12-31: $1.03B2012-12-31: $1.20B2013-12-31: $1.08B2014-12-31: $1.34B2015-12-31: $2.17B2016-12-31: $1.75B2017-12-31: $1.06B2018-12-31: $2.39B2019-12-31: $2.81B2020-12-31: $2.70B2021-12-31: $6.23B2022-12-30: $10.07B2023-12-31: $7.11B2024-12-31: $3.98B2025-12-31: $3.23B$10.07B$0.00
1989-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

NUE operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 37 observations from Dec 31, 1989 to Dec 31, 2025.

Nucor Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
3,234,000,000
3,979,000,000
7,112,000,000
10,072,000,000
6,230,776,000
2,696,877,000
2,809,413,000
2,393,952,000
1,055,338,000
1,750,001,000
2,168,761,000
1,342,898,000
1,077,949,000
1,200,385,000
1,031,053,000
866,794,000
1,173,194,000
2,498,728,000
1,935,306,000
2,251,233,000
2,136,615,000
1,024,756,000
494,619,927
497,219,905
495,115,325
820,754,667
604,800,000
641,900,000
577,300,000
450,600,000
447,200,000
424,900,000
271,800,000
205,400,000
173,400,000
214,300,000
98,000,000

Compare operating cash flow (statement)

All NUE financial metrics · NUE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.